AVIR stock icon

Atea Pharmaceuticals

3.50 USD
+0.06
1.74%
At close Nov 8, 4:00 PM EST
After hours
3.47
-0.03
0.86%
1 day
1.74%
5 days
7.03%
1 month
2.64%
3 months
0.00%
6 months
-10.94%
Year to date
9.03%
1 year
6.38%
5 years
-88.46%
 

About: Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Employees: 75

0
Funds holding %
of 6,759 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

2.24% more ownership

Funds ownership: 65.5% [Q1] → 67.75% (+2.24%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

3% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 37

6% less funds holding

Funds holding: 111 [Q1] → 104 (-7) [Q2]

15% less capital invested

Capital invested by funds: $223M [Q1] → $189M (-$33.9M) [Q2]

35% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 20

94% less call options, than puts

Call options by funds: $297K | Put options by funds: $5.37M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$6.88
97%
upside
Avg. target
$6.88
97%
upside
High target
$6.88
97%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Morgan Stanley
Matthew Harrison
47% 1-year accuracy
7 / 15 met price target
97%upside
$6.88
Equal-Weight
Upgraded
13 Aug 2024

Financial journalist opinion

Based on 4 articles about AVIR published over the past 30 days

Charts implemented using Lightweight Charts™